|Mr. Charles S. Cotropia||CEO, Pres & Director||N/A||N/A||N/A|
|Mr. Rodney Barrington||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Harry H. Zhabilov Jr.||CSO & Director||N/A||N/A||1967|
|Dr. Joseph P. Cotropia M.D.||Chief Medical Officer||N/A||N/A||N/A|
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
Enzolytics Inc. ’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.